Recently visited unit
name Price (yuan) Rise and fall
The following are popular stocks
Please check the self selected shares first
join remind View in APP

Dongcheng Pharmaceutical (002675.SZ)

Questioning stocks
@change@
@changeP@
@now@
Limit: @ up_limit@
Limit: @ down_limit@
Suspension
@date@ @time@
Temporary suspension
Today: @open@ Volume: @volume@ Amplitude: @swing@
Maximum: @high@ Turnover: @amount@ turnover rate: @turnover@
Minimum: @low@ Total Market Value: @fixTotalShare@ P/B ratio: @pb@
Received yesterday: @preClose@ Circulation value: @cvs@ P/E ratio TTM @pe@
Total share capital: @zgb@ Circulating shares: @ltgb@
Information mine:
    The browser version is too low to view the multi null inversion

    Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox Google

    Time-sharing
    Day K
    Week K
    Month K
    K line
    Reinstatement K line
    Technical drawings
    Also concerned:
      5th gear disc opening
      Live broadcast of famous teachers
      Commission ratio -- Abandonment --
      Selling ⑤ -- --
      Sell ④ -- --
      Selling ③ -- --
      Sell ② -- --
      Selling ① -- --
      deal --
      Buy ① -- --
      Buy ② -- --
      Buy ③ -- --
      Buy ④ -- --
      Buy ⑤ -- --
      Outer disc -- Inner disc --

      In case of a key big order, the main force may**

      Quickly use level2 to view details>
      time Price (yuan) Measurement (hand) nature
      time Price (yuan) Measurement (hand) nature
      Transaction price (yuan) Trading volume (hand) Proportion (%)
      time Transaction price (yuan) Trading volume (hand)
      Product entry: Sina Finance APP - Stocks - Investment Research Report
      Product entrance: Sina Finance APP - stock - free question
      Product entrance: Sina Finance APP - stock - free question
      Main and retail investors' capital flow
      Main buy Main sales Purchase by retail investors Retail sales
      Amount (10000 yuan) @mainIn@ @mainOut@ @retailIn@ @retailOut@
      proportion @mainInP@ @mainOutP@ @retailInP@ @retailOutP@
      Loose bill
      Small order
      Large order
      Extra large order
      Net inflow of classified funds
      Loose bill Small order Large order Extra large order
      Net inflow (10000 yuan) @r3_r_in@ @r2_r_in@ @r1_r_in@ @r0_r_in@
      Proportion in the flow board @r3_p_svs@ @r2_p_svs@ @r1_p_svs@ @r0_p_svs@
      Proportion in turnover rate @r3_p_turnover@ @r2_p_turnover@ @r1_p_turnover@ @r0_p_turnover@
      title click reply Final reply

      Company research

      Hot data

      more
      Adjacent ranking
      Top 10 in the industry

      Financial ratios

      more
      Adjacent ranking
      Top 10 in the industry

      Investment rating of research institutions

      more

      In the last 60 days Three research reports released Dongcheng Pharmaceutical (sz002675) rating, and the comprehensive rating is as follows:

      Hot columns

      Industry comparison

      name Price (yuan)

      corporate name:

      Yantai Dongcheng Pharmaceutical Group Co., Ltd

      Main business:

      R&D, production and sales of heparin sodium and chondroitin sulfate.

      Telephone: 0535-6371119

      Fax: 0535-6371119

      Date of establishment: 1998-12-31

      Listing date: 2012-05-25

      Legal representative: You Shouyi

      general manager: Luo Zhigang

      Registered capital: 824.596 million yuan

      Issue price: 26.000 yuan

      Latest total share capital: 824595705 shares

      Latest outstanding shares: 743362675 shares

      Segment: Shenzhen A-share Shanghai and Shenzhen A-share Shenzhen Composite Index Manufacturing index Pharmaceutical index Yellow River Delta Pharmaceuticals Shenzhen Stock Connect Shenzhen Stock Connect Concept of reorganization Shenzhen Stock Index Specialization, refinement and novelty

      2024-03
      2023-12
      2023-09
      2023-06
      2023-03
      Earnings per share 0.0780 yuan 0.2543 yuan 0.3466 yuan 0.2235 yuan 0.0608 yuan
      net asset value per share 6.0728 yuan 5.7912 yuan 6.0826 yuan 5.8779 yuan 5.8125 yuan
      Net operating cash flow per share -0.2005 yuan 0.3359 yuan 0.1211 yuan 0.0148 yuan -0.1126 yuan
      Return on net assets 1.28% 4.39% 5.70% 3.80% 1.05%
      Undistributed profit per share 1.7305 yuan 1.6525 yuan 1.7731 yuan 1.6500 yuan 1.6373 yuan
      Capital reserve per share 3.0508 yuan 2.8386 yuan 3.0411 yuan 2.9616 yuan 2.9089 yuan
      Date of announcement Allocation scheme
      2024-06-15 RMB 1.25 for 10 pies
      2023-07-01 10 Pairs 1.5 yuan
      2022-05-31 10 Pairs 1.5 yuan
      2021-05-28 10 pies 2.5 yuan
      2020-05-21 10 pies 2.5 yuan
      2024-03
      2023-12
      2023-09
      Name of shareholders Shareholding (%) Increase or decrease
      Yantai Dongyi Biotech Co., Ltd sixteen point eight zero one Unchanged
      sugus four point three seven three Unchanged
      PACIFIC... three point seven two zero Unchanged
      You Shouyi three point four seven four Unchanged
      Shanghai Gaoyi Asset Management Co., Ltd two point eight nine two Overweight
      HKSCC has two point one five two Overweight
      Tang Zheng one point five seven nine Overweight
      Nanjing Shijiarong Enterprise one point two one eight New progress
      Huaxia Life Insurance Co., Ltd one point two one five reduce one's shares in a listed company
      Li Zhaoyuan one point one one zero New progress

      Shareholding ratio of circulating shareholders



      user name:
      Password: